Addressing racial disparities in Alzheimer's disease among African Americans
Reducing racial disparities in AD/ADRD: Addressing structural discrimination and resilience
This study is looking to understand and address the unfair differences in Alzheimer's disease and related conditions that impact African Americans, by creating new ways to measure discrimination and resilience, so we can find better ways to help those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11015368 on NIH RePORTER |
What this research studies
This research aims to tackle the significant racial disparities in Alzheimer's disease and related dementias (AD/ADRD) that disproportionately affect African Americans. The project will develop a new measure to assess structural discrimination and resilience, which will help predict outcomes in AD/ADRD. By understanding these factors, the research seeks to create targeted interventions that can reduce the prevalence of AD/ADRD and enhance resilience among affected individuals. The approach involves collaboration with key stakeholders to ensure that the developed tools are relevant and effective.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals who are at risk for or diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients who are not of African American descent or those without any risk factors for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in Alzheimer's disease rates among African Americans and improve overall health outcomes.
How similar studies have performed: Other research has shown success in addressing health disparities through community engagement and targeted interventions, suggesting that this approach may also be effective.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Szanton, Sarah L — Johns Hopkins University
- Study coordinator: Szanton, Sarah L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.